XERIS BIOPHARMA HOLDINGS INC XERS 5 07.15.25
NOTE 5.000% 7/1 · US DOMESTIC · CUSIP 98422LAA5
3
institutional holders
+0 vs Q1 2024
$14.7mprincipal reported held*
$15.2mreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 7 |
| Q4 2022 | 7 |
| Q1 2023 | 7 |
| Q2 2023 | 6 |
| Q3 2023 | 4 |
| Q4 2023 | 4 |
| Q1 2024 | 3 |
| Q2 2024 | 3 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 2 |
| Q1 2023 | 1 | 1 |
| Q2 2023 | 2 | 1 |
| Q3 2023 | 0 | 2 |
| Q4 2023 | 0 | 0 |
| Q1 2024 | 1 | 1 |
| Q2 2024 | 0 | 0 |
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| LAZARD ASSET MANAGEMENT LLC 0.01% of their portfolio | 11.5m $12.0m | Unchanged |
| 683 Capital Management, LLC 0.34% of their portfolio | 3.2m $3.2m | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |